WWE Elimination Chamber 2026 takes place February 28 at Chicago’s United Center. Events feature CM Punk vs. Finn Bálor; Becky Lynch vs. AJ Lee. Randy Orton, Tiffany Stratton, and Rhea Ripley will ...

With Elimination Chamber fast approaching, WWE used Raw on Monday night to continue building out the card for the premium live event. Included in additions to the Elimination Chamber card is a world ...

Rhea Ripley earned the second place in the incumbent Women's Elimination Chamber, beating Lyra Valkyria and Ivy Nile in a triple threat during "WWE Raw." The three women were competing to find out who ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

The United States could soon no longer be a country considered free of measles. The Pan American Health Organization, the part of the World Health Organization that tracks infectious disease in the ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

The South Florida Water Management District held a python hunt in December with cash prizes. Kevin Pavlidis won multiple awards, including for most pythons captured and the longest python. The ...

Wildlife experts in Florida continue to prioritize the elimination of invasive Burmese pythons. A presentation on the impact of pythons will be given by scientist Michael Kirkland on Sanibel Island.

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...